Stock Ticker

  • Loading stock data...

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Strengthens Itself In Battle To Acquire Allergan, Inc. (NYSE:AGN)

Boston, MA 09/25/2014 (wallstreetpr) – Valeant Pharmaceuticals Intl Inc (NYSE:VRX) yesterday said that its revenue for Q3, 2014 will be stronger than anticipated. The company pushed Allegan harder to accept its offer on this pretext. Better-Than-Expected Results Formerly known as Biovail Corporation, Valeant, said it expects the following quarter’s revenue figures to be higher than those […]